← Browse by Condition
Medical Condition

genital neoplasm female

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05592626 Phase 1, Phase 2
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Enrollment
365 pts
Location
United States, Canad...
Sponsor
Marengo Therapeutics, Inc.
View Trial →